Technical Description
The present invention relates to an efficient and multifunctional carbamate-based tryptamine derivative that acts as a potent cholinesterase inhibitor for the management of Alzheimer’s disease.
Problems Addressed
- Expensive
- Inefficient Cholinesterase Inhibition
- Weak Antioxidant Properties
- Lacks Aβ Aggregation Inhibition
- Low Selectivity
Tech Features
- Alzheimer’s Disease Management
- Cholinesterase Inhibition
- Inhibits Aβ Aggregation
- Improved Therapeutic Efficacy
- Delayed AD progression
- Antioxidant Activity
- Multifunctional Properties
- Neurodegeneration Prevention
- Highly Selective
- BBB Permeability
Target Audience
- Healthcare & Medical Sector
- Diagnostic Industry
- Pharmaceutical Industry
- Biotechnology Industry
- Research & Development
Tech ID: P27-1482 TRL 4 Patent Status: Published Available For Exclusive and Non-exclusive License
